Loading insider details...
Latest Form 4 (Oct 30, 2026): Grant/Award of 130,000 GANX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 30, 2026 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 130,000 | n/a |